IBD, these intestinal diseases which do not spare young people

On the occasion of World IBD Day, the hepato-gastroenterology department of the Nîmes University Hospital, in partnership with the François Aupetit Association (AFA), will hold an information and awareness stand on this pathology which affects almost 1 in 10 French people.

Inflammatory bowel diseases (or IBD) include Crohn’s disease (CD) and ulcerative colitis (UC). Both are characterized by inflammation of the wall of part of the digestive tract, due to deregulation of the intestinal immune system. This uncontrolled inflammation is responsible for tissue damage and the chronicity of the disease. Its origin seems to result from the complex combination of environmental factors, associated with a genetic susceptibility of the patient and the particular reactivity of his immune system.

A little-known disease that affects young people

Diagnosed between the ages of 20 and 30, the frequency of IBD varies from one country to another, particularly due to the country’s level of development. These pathologies, which also affect 15% of children, affect almost 300,000 people in France. Abdominal pain, diarrhea, and sometimes damage to the anal region, the symptoms of IBD, culturally remain taboo and talking about it sometimes remains a difficult step to overcome for those affected. The Day of May 22, developed around information and awareness, has existed for more than ten years to break this taboo and free speech.

Diagnosis and treatment at Nîmes University Hospital

A care pathway dedicated to patients with IBD has been organized since 2014 within the University Hospital, coordinated by Dr Ludovic CAILLO, hepato-gastroenterologist and Ms Audrey BOREL, IBD nurse coordinator.

“The diagnosis of IBD (Crohn’s or UC) is based on a combination of clinical, biological and morphological arguments. Patients who consult us thus access the technical digestive endoscopy platform of the CHU to search for digestive lesions via gastroscopy, colonoscopy, rectosigmoidoscopy, or a video capsule,” explains Dr Ludovic CAILLO. “As soon as the diagnosis is made, we organize personalized and individual care” indicates Ms. Audrey BOREL, “by involving different health actors from the hepato-gastroenterology department: Doctors, IDE, Social worker, Psychologist, Dietician, Pharmacist “.

At the Nîmes University Hospital, the patient has a course including treatment and therapeutic education programs on IBD, in partnership with the AFA Crohn RCH France association. As part of their follow-up, patients can have access in gastroenterology at the University Hospital to full hospitalization and day services for the administration of emergency or induction treatments in the event of a severe flare-up or scheduled intravenous biotherapies. at regular intervals for maintenance treatments.

On the external follow-up side (consultations, outpatient), a coordination unit has been set up, managed by a consultation nurse trained in the management of patients with IBD, the detection of flare-ups and treatment failures, the administration and information about innovative subcutaneous and oral therapies.

Dr Ludovic CAILLO finally specifies that “as part of sharing experience and strong collaboration between our hospitals, we are organizing multidisciplinary consultation meetings in partnership with the Montpellier University Hospital. We also participate in numerous clinical research protocols allowing patients to have access to new therapeutic strategies or innovative treatments.”



PREV Olympic 2024 exhibition: the 10 visits to make according to Vogue France
NEXT In Loire-Atlantique, drivers worried after the elimination of adapted transport for 450 disabled students